Day hospital as an alternative to inpatient care for cancer patients: A random assignment trial

Mor, Vincent; Stalker, Martha Z.; Gralla, Richard J.; Scher, Howard I.; Cimma, Claudia; Park, Donna; Flaherty, Anne Marie C.; Kiss, Margaret E.; Nelson, Paul N.; Laliberte, Linda; Schwartz, Rachel; Marks, Paul A.; Oettgen, Herbert F.

doi:10.1016/0895-4356(88)90164-3

Cited by 77 publications

(31 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…2 Grading criteria for studies identified [11] were less likely to assess new symptoms and wound care daily, despite similar staffing levels UK were identified. Two studies of giving chemotherapy and two reports of offering massage in a day-care setting were excluded since they concerned the specific therapy rather than the whole package of day-care provided [31][32][33]. Also excluded was one preliminary report of offering some services in an outpatient clinic [34], a description of one service with no patient outcome data [35] and two discussion papers [36,37].…”

Section: Qualitativementioning

confidence: 99%

Systematic review of specialist palliative day-care for adults with cancer

Davies

Higginson

2005

Support Care Cancer

View full text Add to dashboard Cite

There is evidence for high satisfaction among patients selected into day-care, but not yet sufficient to judge whether this improves symptom control or health-related quality of life. Further research should explore selection and access into care, the most effective models of care, its cost, and potential benefits for relatives and carers. Comparison with models of care for older adults and those with mental illness would also be informative.

show abstract

Section: Qualitativementioning

confidence: 99%

Systematic review of specialist palliative day-care for adults with cancer

Davies

Higginson

2005

Support Care Cancer

View full text Add to dashboard Cite

show abstract

“…This model of care is not prevalent in the US or Europe, although variations of the service exist [2,3,4,5,6]. There is international interest in what benefits palliative day care may provide (Hospice Information Service, personal communication).…”

Section: Introductionmentioning

confidence: 99%

What is palliative day care?

Goodwin

Higginson

Myers

et al. 2002

Support Care Cancer

View full text Add to dashboard Cite

The goals of the work described in this paper were to describe palliative day care from the patient's perspective. Five palliative day care centres in the UK are described. The study subjects were new referrals to the five palliative day care centres, which provided facilities for medical and nursing assessment and also for social and therapeutic activities. This reflects the range of palliative day care services provided in the London region. Three interviews were carried out with each patient over a 3-month period. The descriptive data were examined for content, and the themes were analysed for the frequency of responses within and between interviews. The responses were also examined within three different models of day care (defined by the services). In all, 120 day care patients were recruited from the five centres. Patients attending for day care were mainly white, over 65 years old, retired, and with a cancer diagnosis. These were a representative sample of day care patients in the London region. Patients attended day care to 'meet people' and 'get them out of home' and found the environment 'nice and friendly'. The relationships with the staff and volunteers were also important, and they enjoyed the various activities. At each interview the most important theme identified was 'meeting people'. For this to be supported it would mean encouraging the activities within day care that provide patients with an environment in which they can meet people. This will mean different things to different people, as highlighted in the different philosophies obtained at individual centres.

show abstract

“…Cisplatin produces higher rates of nausea/vomiting and nephrotoxicity, whereas carboplatin results in significantly more thrombocytopenia. Of note, contrary to previous recommendations for a 24-hour hospitalization following cisplatin infusion to reduce the risk for nephrotoxicity, several randomized trials and a retrospective analysis have confirmed that intermediate-to high-dose cisplatin may be safely administered in an outpatient setting using a short hydration regimen [21,22].…”

Section: Evidence From Meta-analysesmentioning

confidence: 79%

Future Scenarios for the Treatment of Advanced Non-Small Cell Lung Cancer: Focus on Taxane-Containing Regimens

Grossi¹,

Kubota

Cappuzzo³

et al. 2010

The Oncologist

View full text Add to dashboard Cite

Despite recent progress in the development of new molecularly targeted agents, the chemotherapy regimens considered standard at the end of the last century-that is, two-drug combinations consisting of either cisplatin or carboplatin plus a third-generation agent (docetaxel, paclitaxel, gemcitabine, or vinorelbine)-remain the primary treatment option for advanced non-small cell lung cancer (NSCLC) patients. Most recently, the existing standard of care has been amended to reflect the significant survival advantage of cisplatin-pemetrexed over cisplatin-gemcitabine as first-line treatment of nonsquamous NSCLC. The addition of a biological drug (bevacizumab, cetuximab) or the use of a singleagent epidermal growth factor receptor inhibitor may further improve outcomes in selected patients.It has become increasingly clear, primarily through recent meta-analyses, that although the therapeutic equivalence of any combination of a platinum agent plus either gemcitabine, vinorelbine, docetaxel, or paclitaxel has been long accepted, each regimen has different side effects and therapeutic outcomes that allow clinicians to select the most appropriate treatment for chemotherapy-naïve patients with stage IIIB/IV NSCLC. In this review, we evaluate the available evidence and explore the role and importance of various modern chemotherapy regimens, with the aim of optimizing treatment selection and combination with biological agents. Emphasis is placed on the role of taxanes (docetaxel versus paclitaxel) in this changing landscape.

show abstract

Day hospital as an alternative to inpatient care for cancer patients: A random assignment trial

Cited by 77 publications

References 22 publications

Systematic review of specialist palliative day-care for adults with cancer

Systematic review of specialist palliative day-care for adults with cancer

What is palliative day care?

Future Scenarios for the Treatment of Advanced Non-Small Cell Lung Cancer: Focus on Taxane-Containing Regimens

Contact Info

Product

Resources

About